ARTICLE | Distillery Therapeutics
MAP3K7, IL18R1 as targets in obesity-related cerebrovascular dysfunction
June 26, 2020 1:32 AM UTC
INDICATION: Obesity; stroke...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Obesity; stroke...
BCIQ Company Profiles
BCIQ Target Profiles